Concepedia
Statistics
Publications
32
Citations
1.5K
H-Index
22
Active since
1989
Affiliations
Pfizer (United States)(Current)
Wake Forest University
Institute for Atherosclerosis Research
Warde Medical Laboratory
National Heart Lung and Blood Institute
Bruce J. Auerbach is an author at Pfizer (United States) specializing in medicine, pharmacology, and biochemistry.
Top concepts
MedicinePharmacologyBiochemistryDrug DiscoveryNatural SciencesMedicinal ChemistryAtherosclerosisPharmacotherapyChemical BiologyVascular Biology
Publications per year
1989–2022
Hypolipidemic activity of select fibrates correlates to changes in hepatic apolipoprotein C-III expression: a potential physiologic basis for their mode of action.
Sabine Haubenwallner, Arnold D. Essenburg, B.C. Barnett et al. · Journal of Lipid Research · 1995 · 120 citations · Full text
A spectrophotometric microtiter-based assay for the detection of hydroperoxy derivatives of linoleic acid
Bruce J. Auerbach, John S. Kiely, Joseph A. Cornicelli · Analytical Biochemistry · 1992 · 104 citations
Spectrophotometric Microtiter-based Assay, Chemical Measurement, Engineering +14
Familial lecithin:cholesterol acyltransferase deficiency: First-in-human treatment with enzyme replacement
Robert D. Shamburek, Rebecca Bakker‐Arkema, Bruce J. Auerbach et al. · Journal of clinical lipidology · 2015 · 94 citations · Full text
Genetic Disorder, Genetics, Inherited Metabolic Disease +4
Lipoprotein abnormalities associated with lipopolysaccharide-induced lecithin:cholesterol acyltransferase and lipase deficiency
Bruce J. Auerbach, John S. Parks · Journal of Biological Chemistry · 1989 · 92 citations · Full text
Safety and Tolerability of ACP-501, a Recombinant Human Lecithin:Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation Study
Robert D. Shamburek, Rebecca Bakker‐Arkema, Alexandra M. Shamburek et al. · Circulation Research · 2015 · 82 citations · Full text
1–5 of 32